EZH2 and glioblastoma: discovered that ZDHHC4 can palmitoylate GSK3β, altering its phosphorylation level and triggering the EZH2/STAT3 axis to increase GBM TMZ-resistance and glioblastoma stem cells (GSCs) tumorigenicity (13).